Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies (original) (raw)
Guruharsha KG, Kankel MW, Artavanis-Tsakonas S . The Notch signalling system: recent insights into the complexity of a conserved pathway. Nat Rev Genet 2012; 13: 654–666. ArticleCASPubMedPubMed Central Google Scholar
Andersson ER, Sandberg R, Lendahl U . Notch signaling: simplicity in design, versatility in function. Development 2011; 138: 3593–3612. ArticleCASPubMed Google Scholar
Fryer CJ, White JB, Jones KA . Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 2004; 16: 509–520. ArticleCASPubMed Google Scholar
Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269–271. ArticleCASPubMed Google Scholar
Gordon WR, Roy M, Vardar-Ulu D, Garfinkel M, Mansour MR, Aster JC et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood 2009; 113: 4381–4390. ArticleCASPubMedPubMed Central Google Scholar
Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC et al. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol 2006; 26: 4642–4651. ArticleCASPubMedPubMed Central Google Scholar
Ntziachristos P, Lim JS, Sage J, Aifantis I . From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 2014; 25: 318–334. ArticleCASPubMedPubMed Central Google Scholar
Ranganathan P, Weaver KL, Capobianco AJ . Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011; 11: 338–351. ArticleCASPubMed Google Scholar
Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 2011; 17: 1646–1651. ArticleCASPubMedPubMed Central Google Scholar
Stoeck A, Lejnine S, Truong A, Pan L, Wang H, Zang C et al. Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov 2014; 4: 1154–1167. ArticleCASPubMedPubMed Central Google Scholar
Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS et al. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 2013; 123: 2965–2968. ArticleCASPubMedPubMed Central Google Scholar
Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N et al. The mutational landscape of adenoid cystic carcinoma. Nat Genet 2013; 45: 791–798. ArticleCASPubMedPubMed Central Google Scholar
Nakayama K, Nakayama N, Jinawath N, Salani R, Kurman RJ, Shih Ie M et al. Amplicon profiles in ovarian serous carcinomas. Int J Cancer 2007; 120: 2613–2617. ArticleCASPubMed Google Scholar
Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, Getz G et al. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res 2009; 15: 1417–1427. ArticleCASPubMedPubMed Central Google Scholar
Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609–615. Article Google Scholar
Aster JC, Blacklow SC . Targeting the Notch pathway: twists and turns on the road to rational therapeutics. J Clin Oncol 2012; 30: 2418–2420. ArticleCASPubMed Google Scholar
Vooijs M, Liu Z, Kopan R . Notch: architect, landscaper, and guardian of the intestine. Gastroenterology 2011; 141: 448–459. ArticlePubMed Google Scholar
Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 2000; 14: 1343–1352. CASPubMedPubMed Central Google Scholar
Huppert SS, Le A, Schroeter EH, Mumm JS, Saxena MT, Milner LA et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 2000; 405: 966–970. ArticleCASPubMed Google Scholar
Limbourg FP, Takeshita K, Radtke F, Bronson RT, Chin MT, Liao JK . Essential role of endothelial Notch1 in angiogenesis. Circulation 2005; 111: 1826–1832. ArticleCASPubMedPubMed Central Google Scholar
McCright B, Gao X, Shen L, Lozier J, Lan Y, Maguire M et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001; 128: 491–502. CASPubMed Google Scholar
Krebs LT, Xue Y, Norton CR, Sundberg JP, Beatus P, Lendahl U et al. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 2003; 37: 139–143. ArticleCASPubMed Google Scholar
Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 2004; 18: 2730–2735. ArticleCASPubMedPubMed Central Google Scholar
Xu X, Choi SH, Hu T, Tiyanont K, Habets R, Groot AJ et al. Insights into autoregulation of Notch3 from structural and functional studies of its negative regulatory region. Structure 2015; 23: 1227–1235. ArticleCASPubMedPubMed Central Google Scholar
Aste-Amezaga M, Zhang N, Lineberger JE, Arnold BA, Toner TJ, Gu M et al. Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors. PloS One 2010; 5: e9094. ArticlePubMedPubMed Central Google Scholar
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603–607. ArticleCASPubMedPubMed Central Google Scholar
Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH et al. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol 2009; 27: 1025–1031. ArticleCASPubMedPubMed Central Google Scholar
Prassler J, Steidl S, Urlinger S . In vitro affinity maturation of HuCAL antibodies: complementarity determining region exchange and RapMAT technology. Immunotherapy 2009; 1: 571–583. CASPubMed Google Scholar
Prassler J, Thiel S, Pracht C, Polzer A, Peters S, Bauer M et al. HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J Mol Biol 2011; 413: 261–278. ArticleCASPubMed Google Scholar
Rauchenberger R, Borges E, Thomassen-Wolf E, Rom E, Adar R, Yaniv Y et al. Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. J Biol Chem 2003; 278: 38194–38205. ArticleCASPubMed Google Scholar
Li K, Li Y, Wu W, Gordon WR, Chang DW, Lu M et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J Biol Chem 2008; 283: 8046–8054. ArticleCASPubMed Google Scholar
Yamaguchi N, Oyama T, Ito E, Satoh H, Azuma S, Hayashi M et al. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 2008; 68: 1881–1888. ArticleCASPubMed Google Scholar
Gordon WR, Vardar-Ulu D, L'Heureux S, Ashworth T, Malecki MJ, Sanchez-Irizarry C et al. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2. PloS One 2009; 4: e6613. ArticlePubMedPubMed Central Google Scholar
Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y et al. Therapeutic antibody targeting of individual Notch receptors. Nature 2010; 464: 1052–1057. ArticleCASPubMed Google Scholar
Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC . Structural basis for autoinhibition of Notch. Nat Struct Mol Biol 2007; 14: 295–300. ArticleCASPubMed Google Scholar
Chiang MY, Xu L, Shestova O, Histen G, L'Heureux S, Romany C et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008; 118: 3181–3194. ArticleCASPubMedPubMed Central Google Scholar
Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 2000; 19: 3337–3348. CASPubMedPubMed Central Google Scholar
Tiyanont K, Wales TE, Siebel CW, Engen JR, Blacklow SC . Insights into Notch3 activation and inhibition mediated by antibodies directed against its negative regulatory region. J Mol Biol 2013; 425: 3192–3204. ArticleCASPubMedPubMed Central Google Scholar
Wang K, Zhang Q, Li D, Ching K, Zhang C, Zheng X et al. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a gamma-secretase inhibitor. Clin Cancer Res 2015; 21: 1487–1496. ArticlePubMed Google Scholar
Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA et al. Gauging NOTCH1 activation in cancer using immunohistochemistry. PloS One 2013; 8: e67306. ArticleCASPubMedPubMed Central Google Scholar
Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841–846. ArticleCASPubMed Google Scholar
Ramasamy SK, Kusumbe AP, Wang L, Adams RH . Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 2014; 507: 376–380. ArticleCASPubMedPubMed Central Google Scholar
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–408. ArticleCASPubMed Google Scholar
Berman H, Henrick K, Nakamura H . Announcing the worldwide protein data bank. Nat Struct Biol 2003; 10: 980. ArticleCASPubMed Google Scholar